These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35586748)

  • 21. Atrial natriuretic peptide in cardiovascular biology and disease (NPPA).
    Song W; Wang H; Wu Q
    Gene; 2015 Sep; 569(1):1-6. PubMed ID: 26074089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension.
    Lynch AI; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Leiendecker-Foster C; Arnett DK
    JAMA; 2008 Jan; 299(3):296-307. PubMed ID: 18212314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA methylation as a biomarker for cardiovascular disease risk.
    Kim M; Long TI; Arakawa K; Wang R; Yu MC; Laird PW
    PLoS One; 2010 Mar; 5(3):e9692. PubMed ID: 20300621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-type natriuretic peptide for prediction of incident clinically significant abdominal aortic aneurysm: A population-based prospective study.
    Acosta S; Gottsäter A; Engström G; Melander O; Zarrouk M; Nilsson PM; Smith JG
    Vasc Med; 2018 Feb; 23(1):46-51. PubMed ID: 29343179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute Metabolic Influences on the Natriuretic Peptide System in Humans.
    Arora P; Wu C; Hamid T; Arora G; Agha O; Allen K; Tainsh RET; Hu D; Ryan RA; Domian IJ; Buys ES; Bloch DB; Prabhu SD; Bloch KD; Newton-Cheh C; Wang TJ
    J Am Coll Cardiol; 2016 Feb; 67(7):804-812. PubMed ID: 26892417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender difference of association between plasma N-terminal pro-atrial natriuretic peptide and metabolic syndrome.
    Guo Q; Zhang Q; He Y; Shi J; Li H; Peng H
    Hormones (Athens); 2020 Dec; 19(4):541-548. PubMed ID: 32617886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure.
    Newton-Cheh C; Larson MG; Vasan RS; Levy D; Bloch KD; Surti A; Guiducci C; Kathiresan S; Benjamin EJ; Struck J; Morgenthaler NG; Bergmann A; Blankenberg S; Kee F; Nilsson P; Yin X; Peltonen L; Vartiainen E; Salomaa V; Hirschhorn JN; Melander O; Wang TJ
    Nat Genet; 2009 Mar; 41(3):348-53. PubMed ID: 19219041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial natriuretic peptide vs. N-terminal-pro-atrial natriuretic peptide for the detection of left atrial dilatation in horses.
    van der Vekens N; Decloedt A; de Clercq D; Ven S; Sys S; van Loon G
    Equine Vet J; 2016 Jan; 48(1):15-20. PubMed ID: 25257480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
    Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
    Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy.
    Rubattu S; Barbato A; Marchitti S; Iacone R; Di Castro S; Evangelista A; Stanzione R; Ippolito R; Sciarretta S; Palmieri L; Volpe M; Strazzullo P;
    J Hypertens; 2010 Aug; 28(8):1638-45. PubMed ID: 20453667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
    Wang TJ; Larson MG; Levy D; Benjamin EJ; Leip EP; Omland T; Wolf PA; Vasan RS
    N Engl J Med; 2004 Feb; 350(7):655-63. PubMed ID: 14960742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global DNA hypermethylation in peripheral blood mononuclear cells and cardiovascular disease risk: a population-based propensity score-matched cohort study.
    Tsuboi Y; Yamada H; Munetsuna E; Fujii R; Yamazaki M; Ando Y; Mizuno G; Ishikawa H; Ohashi K; Hashimoto S; Hamajima N; Suzuki K
    J Epidemiol Community Health; 2021 Sep; 75(9):890-895. PubMed ID: 33766847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alcohol-induced changes in methylation status of individual CpG sites, and serum levels of vasopressin and atrial natriuretic peptide in alcohol-dependent patients during detoxification treatment.
    Glahn A; Riera Knorrenschild R; Rhein M; Haschemi Nassab M; Gröschl M; Heberlein A; Muschler M; Frieling H; Bleich S; Hillemacher T
    Eur Addict Res; 2014; 20(3):143-50. PubMed ID: 24356727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The natriuretic peptide MR-proANP predicts all-cause mortality and adverse outcome in community patients: a 10-year follow-up study.
    Odermatt J; Hersberger L; Bolliger R; Graedel L; Christ-Crain M; Briel M; Bucher HC; Mueller B; Schuetz P
    Clin Chem Lab Med; 2017 Aug; 55(9):1407-1416. PubMed ID: 28107168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial natriuretic peptide predicts disease progression and digital ulcers development in systemic sclerosis patients.
    Romaniello A; Rubattu S; Gigante A; Simonelli F; Grimaldi MC; D'Angelo A; Alunni D; Sada L; Gasperini ML; Marchitti S; Volpe M; Rosato E
    J Cardiovasc Med (Hagerstown); 2019 Nov; 20(11):771-779. PubMed ID: 31397686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
    Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
    Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides.
    Ichiki T; Huntley BK; Sangaralingham SJ; Burnett JC
    JACC Heart Fail; 2015 Sep; 3(9):715-23. PubMed ID: 26362447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study.
    Cannone V; Huntley BK; Olson TM; Heublein DM; Scott CG; Bailey KR; Redfield MM; Rodeheffer RJ; Burnett JC
    Hypertension; 2013 Nov; 62(5):860-5. PubMed ID: 24041948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.